TipRanks
Go Ultimate55% OFF

Arrowhead Pharmaceuticals (ARWR) Balance Sheet

Arrowhead Pharmaceuticals Balance Sheet

Arrowhead Pharmaceuticals's total assets for Q3 2026 were $2.11B, a decrease of 6.89% from the previous quarter. MX:ARWR total liabilities were $1.65B for the fiscal quarter, a 1.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetSep 25Sep 24Sep 23Sep 22Sep 21
$ 1.39B$ 1.14B$ 765.55M$ 691.94M$ 710.15M
$ 881.88M$ 948.74M$ 478.39M$ 273.60M$ 301.33M
$ 503.42M$ 191.06M$ 287.16M$ 418.34M$ 408.82M

Currency in USD

Arrowhead Pharmaceuticals Debt to Assets

0500M1B1.5B0 %30 %60 %90 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets